Literature DB >> 25976069

Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.

Piotr Adamowicz1, Bogdan Tokarczyk1.   

Abstract

In recent years, many new psychoactive substances (NPS) from several drug classes have appeared on the drug market. These substances, also known as 'legal highs', belong to different chemical classes. Despite the increasing number of NPS, there are few comprehensive screening methods for their detection in biological specimens. In this context, the purpose of this study was to develop a fast and simple liquid chromatography-tandem mass spectrometry (LC-MS/MS) screening procedure for NPS in blood. The elaborated method allows the simultaneous screening of 143 compounds from different groups (number of compounds): cathinones (36), phenethylamines (26), tryptamines (18), piperazines (9), piperidines (2), synthetic cannabinoids (34), arylalkylamines (7), arylcyclohexylamines (3), aminoindanes (2), and other drugs (6). Blood samples (0.2 mL) were precipitated with acetonitrile (0.6 mL). The separation was achieved with gradient mobile phase of 0.1% formic acid in acetonitrile and 0.1% formic acid in water in 14 min. Detection of all compounds was based on multiple reaction monitoring (MRM) transitions. The total number of transitions monitored in dynamic mode was 432. The whole procedure was rapid and simple. The limits of detection (LODs) estimated for 104 compounds were in the range 0.01-3.09 ng/mL. The extraction recoveries determined for 32 compounds were from 1.8 to 133%. The procedure was successfully applied to the analysis of forensic blood samples in routine casework. The developed method should have wide applicability for rapid screening of new drugs of abuse in forensic or clinical samples. The procedure can be easily expanded for more substances.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS/MS; blood analysis; drug screening; legal highs; new psychoactive substances (NPS)

Mesh:

Substances:

Year:  2015        PMID: 25976069     DOI: 10.1002/dta.1815

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  12 in total

1.  Fatalities associated with NPS stimulants in the Greater Cologne area.

Authors:  Sabrina Lehmann; Tobias Kieliba; Mario Thevis; Markus A Rothschild; Katja Mercer-Chalmers-Bender
Journal:  Int J Legal Med       Date:  2019-11-18       Impact factor: 2.686

Review 2.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

3.  Development and validation of a rapid LC-MS/MS method for the detection of 182 novel psychoactive substances in whole blood.

Authors:  Arianna Giorgetti; Rossella Barone; Guido Pelletti; Marco Garagnani; Jennifer Pascali; Belal Haschimi; Volker Auwärter
Journal:  Drug Test Anal       Date:  2021-10-21       Impact factor: 3.234

Review 4.  Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs.

Authors:  Francesco Paolo Busardo; Simona Pichini; Manuela Pellegrini; Angelo Montana; Alfredo Fabrizio Lo Faro; Simona Zaami; Silvia Graziano
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.

Authors:  Claude Guillou; Fabiano Reniero; Joana Lobo Vicente; Margaret Holland; Kamil Kolar; Hubert Chassaigne; Salvatore Tirendi; Herve Schepers
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

Review 6.  The emergency department care of the cannabis and synthetic cannabinoid patient: a narrative review.

Authors:  Kevin M Takakuwa; Raquel M Schears
Journal:  Int J Emerg Med       Date:  2021-02-10

Review 7.  Toxicology and Analysis of Psychoactive Tryptamines.

Authors:  Sara Malaca; Alfredo Fabrizio Lo Faro; Alice Tamborra; Simona Pichini; Francesco Paolo Busardò; Marilyn A Huestis
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

Review 8.  Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.

Authors:  Sumit Sethi; Elisa Brietzke
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-09       Impact factor: 5.176

9.  Blood concentrations of a new psychoactive substance 4-chloromethcathinone (4-CMC) determined in 15 forensic cases.

Authors:  Ewa Tomczak; Mateusz Kacper Woźniak; Marzena Kata; Marek Wiergowski; Beata Szpiech; Marek Biziuk
Journal:  Forensic Toxicol       Date:  2018-05-28       Impact factor: 4.096

10.  High-Throughput Qualitative and Quantitative Drug Checking by MALDI HRMS.

Authors:  Timothée Joye; Christèle Widmer; Roxane Morger Mégevand; Serge Longère; Marc Augsburger; Aurélien Thomas
Journal:  Front Chem       Date:  2020-08-25       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.